March 3, 2025
 
 

Small Stocks, Big Money™

Weekly Newsletter
REDCHIP.COM
 
 
BullFrog AI Partners with Eleison Pharmaceuticals to Optimize Phase 3 Oncology Trial Using AI
 
BullFrog AI (Nasdaq: BFRG) is teaming up with Eleison Pharmaceuticals to enhance Eleison’s pivotal Phase 3 trial for glufosfamide, an investigational pancreatic cancer treatment. Utilizing its bfLEAP® AI technology, BullFrog AI will analyze clinical data to refine patient selection, improve trial efficiency, and accelerate drug development. With pancreatic cancer impacting over 510,000 people worldwide annually and limited treatment options available, this collaboration aims to bring life-saving therapies to market faster. Eleison expects to complete the trial in 2027.
 
 
 
 
 
 
 
 
 
ConnectM Slashes Debt by $31M, Eyes Debt-Free Status by Q2 2025
 
ConnectM Technology Solutions (Nasdaq: CNTM) continues its financial turnaround, eliminating $31 million in liabilities since going public and reducing outstanding debt to under $10 million. With a $45 million revenue run rate and expectations to reach operating cash flow breakeven in Q1 2025, the company is on track to be debt-free by Q2. As a leader in AI-powered electrification solutions, ConnectM is positioning itself for strong growth in the clean energy sector.
 
 
 
 
 
 
 
VSee Health Partners with LanguageLine to Eliminate Language Barriers in Telehealth
 
VSee Health (Nasdaq: VSEE) enhanced its telehealth platform through a strategic partnership with LanguageLine Solutions, enabling seamless, real-time interpreter access in over 240 languages. With the global digital health market projected to surpass $787 billion, this collaboration is expected to drive adoption, improve provider efficiency, and unlock new revenue streams. By integrating one-touch language support, VSee is breaking down barriers to virtual care, ensuring equitable healthcare access for diverse patient populations while strengthening its position in the fast-growing telehealth sector.
 
 
 
 
 
 
 
 
 
 
Better Choice Company Moves Forward with $125M Acquisition of SRx Health Solutions
 
Better Choice Company (NYSE American: BTTR) has received final court approval to proceed with its $125 million acquisition of SRx Health Solutions, a leading Canadian specialty pharmacy provider. The combined company is expected to generate $270M+ in revenue and $10M+ in EBITDA in 2025, positioning itself as a global leader in health and wellness solutions. SRx shareholders will own approximately 85% of the new entity, with Better Choice shareholders retaining 15%. A special shareholder meeting is set for March 21, 2025, to finalize the transaction, which is expected to close in Q2 2025.
 
 
 
 
 
 
 
Gorilla Technology Showcased in Nasdaq Amplify Spotlight, Highlighting AI-Driven Global Expansion
 
Gorilla Technology (Nasdaq: GRRR) was featured in the Nasdaq Amplify Issuer Spotlight, where CEO Jay Chandan discussed the company’s AI-powered innovations in smart cities, cybersecurity, and sustainability. With a consultative approach tailored to government and enterprise needs, Gorilla is driving next-gen security and intelligence solutions worldwide. The feature reinforces the company's growing role in global AI adoption and digital transformation, solidifying its position as a leader in smart infrastructure and data-driven security.
 
 
 
 
 
Recent News
 
 
 
 
 
 
 
 
 
 
 
 
Unlock Smarter Investing with RedChat
 
Tired of sifting through endless filings? Let RedChat do the heavy lifting. Get real-time, data-driven insights on over 2,000 small-cap stocks—instantly. Save time, make informed decisions, and stay ahead of the market.
Access RedChat now, free of charge.
 
 
 
 
 
Recent Research Coverage Updates
 
Company Rating Price Target Firm Report Date
Enlivex Therapeutics (NASDAQ: ENLV) Buy $13 D. Boral February 7, 2025
Gorilla Technology Group (NASDAQ: GRRR) Buy $18 Northland Capital Markets January 22, 2025
OS Therapies (NYSE American: OSTX) Buy $9 Brookline January 15, 2025
OS Therapies (NYSE American: OSTX) Buy $15 Maxim January 15, 2025
OS Therapies (NYSE American: OSTX) Buy $20 D Boral Capital January 15, 2025
Gorilla Technology Group (NASDAQ: GRRR) Buy $3 ThinkEquity January 13, 2025
Venu Holding Corp. (NYSE American: VENU) Buy $15 ThinkEquity January 6, 2025
Gorilla Technology Group (NASDAQ: GRRR) Buy $27 Alliance Global Partners January 2, 2025
Alliance Entertainment (NASDAQ: AENT) Buy $8 ThinkEquity December 16, 2024
Nova Minerals (NASDAQ: NVA) Buy $25 ThinkEquity December 7, 2024
Calidi Biotherapeutics (NYSE American: CLDI) Buy $10 Ladenburg Thalmann November 21, 2024
Fathom Holdings (NASDAQ: FTHM) Buy $3.75 Roth November 8, 2024
ASP Isotopes (Nasdaq: ASPI) Buy $4.50 Cannacord Genuity October 4, 2024
GreenPower Motor (Nasdaq: GP) Buy $3 RF Lafferty September 11, 2024
Enlivex Therapeutics (Nasdaq: ENLV) Buy $13 EF Hutton August 27, 2024
GreenPower Motor (Nasdaq: GP) Buy $1.65 Roth August 15, 2024
Fathom Holdings (NASDAQ: FTHM) Buy $3 DA Davidson August 13, 2024
 
 
 
 
Small Stocks, Big Money™ Podcast
 
The podcast features in-depth interviews with CEO’s from the top names in small-cap stocks, providing listeners with a unique perspective not found anywhere else.
Available on:
amazon music apple music spotify music
 
 
 
 
 
 
Upcoming Events
 
 
4
 
 
MAR 2025
 
NASDAQ: CNTM - ConnectM Technology Solutions
4:15pm Eastern
 
ConnectM Technology Solutions is accelerating the transition to an all-electric, net-zero carbon future through its AI-driven energy intelligence platform.
 
 
 
 
 
 
 
6
 
 
MAR 2025
 
NASDAQ: PEV - Phoenix Motorcars
4:15pm Eastern
 
Phoenix Motor Inc is an electrification solutions provider for the commercial vehicle industry as well as other industries.
 
 
 
 
 
 
 
11
 
 
MAR 2025
 
RedChat
04:15pm Eastern
 
RedChip Companies has launched RedChat, a cutting-edge AI chatbot designed to revolutionize small-cap stock research.
 
 
 
 
 
 
 
13
 
 
MAR 2025
 
NASDAQ: FTHM - Fathom Holdings
4:15pm Eastern
 
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent.
 
 
 
 
 
 
 
Archived Events
 
 
27
 
 
Feb 2025
 
NYSE American: OSTX - OS Therapies
4:15pm Eastern
 
OS Therapies, a clinical stage biopharmaceutical company, is at the forefront of developing innovative treatments for Osteosarcoma (OS), breast cancer and other solid tumors.
 
 
 
 
 
 
26
 
 
Feb 2025
 
NASDAQ: GP - GreenPower Motor Company
4:15pm Eastern
 
GreenPower Motor Company is advancing the adoption of electric vehicles (EVs) by making all-electric buses and trucks affordable, durable and easy to deploy.
 
 
 
 
 
 
 
25
 
 
Feb 2025
 
NYSE American: CANF - Can-Fite Biopharma
4:15pm Eastern
 
Can Fite Biofarma Ltd is an clinical-stage biopharmaceutical company. The company develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases.
 
 
 
 
 
 
 
24
 
 
FEB 2025
 
NASDAQ: AENT - Alliance Entertainment Holding
11:00am Eastern
 
Alliance Entertainment is the global leader in physical media distribution, acting as the crucial gateway between major content producers and retailers.
 
 
 
 
 
 
Quote of the Week
 
"There are exceptions and dumb luck, but you have to be savvy in this space."
— Greg Sichenzia, Founding Partner Sichenzia Ross Friedman Ference
 
 
RedChip TV
 
 
 
 
RedChip Highlights Calidi Biotherapeutics (NYSE American: CLDI) & OS Therapies (NYSE American: OSTX)
 
 
 
 
 
 
 
Order "Small Stocks, Big Money™ Today!
 
Dave Gentry's new book, Small Stocks, Big Money: Interviews With Microcap Superstars, is now available for pre-order. Published by Wiley Finance, this first-hand perspective and insider information on the fast world of microcap investing is now available for purchase.
 
 
 
 
 
 
 
Lesson of the Week
 
Read an interesting perspective on liquidity from leading small-cap manager, Michael Corbett at Perritt Capital.